Last updated: 2026-09-16 10:32:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
SeaStar Medical Holding Corporation (ICU) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.98, with a market capitalisation of $13.53M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.07 to $12.50. This page covers its latest market performance, valuation, price trends and company information.
$13.53M | |
$2.98 | |
$3,050.00 | |
$2.07 | |
$3.02 | |
-- | |
77.84K | |
-- | |
$12.50 | |
$2.07 | |
-- | |
-- |
SeaStar Medical Holding Corporation (ICU) is trading at $2.98 in pre-market trading as of 2026-09-16 08:01:00, down 1.46% ($0.04) from the previous close of $3.02
Pre-market trading shows how investors are pricing ICU before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, SeaStar Medical Holding Corporation (ICU) moved from $2.98 to $2.98, representing a decline of 0.13% ($0.00).
The stock traded between $2.84 and $3.34 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 38.67 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 8.7%
ICU is currently trading at $2.98, placing it 8.7% of the way from its 52-week low of $2.07 to its 52-week high of $12.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of SeaStar Medical Holding Corporation (ICU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.